Taiwan's Academia Sinica said Friday that it has screened out protease inhibitors of the COVID-19 coronavirus, which could eventually lead to the development of targeted drugs to stop the virus from replicating itself in patients' bodies.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Cross-Strait
- Society
Downpours forecast for northern, eastern Taiwan early next week
10/15/2025 11:41 AM - Business
U.S. dollar down in Taipei trading
10/15/2025 10:45 AM - Society
Taiwan headline news
10/15/2025 10:34 AM - Business
Taiwan shares open higher
10/15/2025 09:15 AM